Smarter Literature Monitoring. Faster Compliance.

Pharmacovigilance teams today face significant challenges:

• The sheer volume of scientific publications makes manual monitoring unsustainable
• Navigating diverse regulatory requirements from agencies like the FDA, EMA, MHRA, and ICH adds complexity
• Manual processes in screening, extraction, and reporting consume valuable time
• Coordinating literature monitoring across multilingual and geographically dispersed teams hinders effective collaboration.

EVERSANA’s Literature Intel Solution, powered by AI-driven intelligence, addresses these challenges head-on. By automating and accelerating safety literature surveillance, it ensures faster detection of adverse events, improved compliance, and reduced operational burden for pharmacovigilance teams.

Reimagine Literature Surveillance with Intelligence That Learns

Traditional manual approaches to literature monitoring are no longer sufficient. EVERSANA’s Literature Intel Solution transforms pharmacovigilance operations by combining AI-driven automation with human expertise. It goes beyond keyword searches to understand context, extract key safety data, and deliver ready-to-submit regulatory reports in real time.

From local journals to global databases, from scanning to processing—we’re simplifying literature intelligence.